The nation of Zimbabwe has turned down a major American healthcare agreement valued at $367m (272 million pounds) spanning five years because of the United States' demand for confidential biological samples.
This rejection became public after a government memo from December was disclosed, revealing that President Emmerson Mnangagwa felt the arrangement was "unbalanced".
A government spokesperson later explained that the US was requesting genetic material for research and commercial purposes while was unwilling to guarantee the resulting advantages from future treatments.
"We will now turn to the difficult and regrettable process of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for further dialogue to reach a agreement acceptable to all parties so the nation's critical HIV treatment initiative can continue.
Wider Context
This development comes after a similar situation in neighbouring Kenya, where a court blocked a similar health funding agreement after concerns were filed about the safety of citizens' health data.
After returning to the presidency recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
The agency had managed aid for the American government, but Trump stated its spending was "inefficient" and his administration was seeking government-to-government deals to boost transparency and responsibility.
As per statements, 16 African countries have to date agreed to similar health pacts, constituting over $18.3bn in new funding.
Details of the Declined Agreement
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy via US-supported programmes," the Ambassador commented.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, without any corresponding promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.
"Put simply, our country would supply the raw materials for scientific discovery with no certainty that the end products would be accessible to our citizens should a new disease outbreak emerge."
National Interest and Global Health
He also pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were disrupting frameworks already established through the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing scheme created to deal with potential pandemics.
"This system is designed to ensure that when a nation provides its data, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the capability to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage continued discussions with our US partners on how subsequent co-operation could be arranged in a way that honours the sovereignty and interests of each country."
Medical Community Response
Medical experts stated it recognised the government's concerns, but suggested that talks should continue given that a large portion of the nation's HIV programmes relied on external financing.
"If specific concerns arise, including those involving data governance or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," it said.
The halted deal emphasises the complex tensions between receiving much-needed foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.